Lucida Medical has raised an £8.7 million funding round, with Empirical Ventures, to scale Pi, its prostate-cancer diagnostic AI.
Lucida Medical's Pi platform integrates into MRI workflows to help radiologists identify prostate cancer faster and more consistently.
The new capital will help the team accelerate development and bring the technology closer to market.
